Article
Potential of Cannabidiol (CBD) to overcome extensively drug-resistant Acinetobacter baumannii
15 Aug 2025
Abstract excerpt
Extensively drug-resistant (XDR) Acinetobacter baumannii poses a serious clinical challenge due to its resistance to nearly all available antibiotics, including carbapenems and colistin. Cannabidiol (CBD), a non-psychoactive phytochemical from Cannabis sativa L., has recently shown promising antimicrobial activity. This study evaluates the antibacterial and anti-biofilm effects of CBD against XDR A. baumannii...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
